metabolic

HGH Frag 176-191 (alt label)

GH C-terminal fragment, alt labelling

0 vendors tracked0 live pricesLast crawl: 2026-06-09 12:03 UTC

About

Alternate vendor labelling of HGH Fragment 176-191. Functionally equivalent; sequence should match via COA.

Also known as: Same sequence as fragment-176-191

Commonly cited research dose ranges

Not medical advice. These are ranges reported in research literature, not personalized recommendations. Consult your physician.

Range250 – 1000 mcg

Study type: Preclinical murine lipolysis studies and early-phase human lipid-metabolism research evaluating the C-terminal fragment of human growth hormone.

Literature notes: Literature reports daily subcutaneous administration in preclinical studies; oral formulations were investigated in early human metabolic research.

Citations

Heffernan et al., Int J Obes Relat Metab Disord, 2001
“Both hGH and its C-terminal fragment (AOD9604) significantly reduced adipose accumulation in obese mice and increased fat oxidation.”
Ng et al., J Endocrinol, 2000
“Oral administration of the synthetic fragment altered lipid metabolism in a dose-dependent manner.”

Last verified: May 3, 2026

Reconstitution calculator

For research purposes only. Not for human consumption. Always verify calculations independently.

VialPeptide mass in vial (mg)mgBacteriostatic water added (mL)mL

DoseDesired dose

Syringe

How reconstitution works · Understanding syringe units

Cost-per-dose recalculates as you adjust the calculator above.

Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.

Keep exploring

More on HGH Frag 176-191 (alt label) & related research